Virus News and Research

Latest Virus News and Research

Bristol-based new biotech company is developing ground-breaking treatments for Covid-19

A team of top scientists from the University of Bristol have announced the formation of a new biotech company that is developing ground-breaking and newly patented potential treatments for Coronavirus.

16 Apr 2021

Recovered COVID-19 patients may need only a single vaccine dose, suggests study

People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published today in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody response.

16 Apr 2021

Researchers probe intriguing interaction between sugars and the SARS-CoV-2 spike protein

A new study posted to the bioRxiv preprint server focuses on a novel formulation of magnetization or saturation transfer. This method is developed by amalgamating theoretical and computational approaches based on a Bayesian deconvolution algorithm, which helps obtain data more accurately and determine the ligand-protein interaction.

16 Apr 2021

Intestinal worm infection can cause severe sexually transmitted viral diseases

Infection with parasitic intestinal worms (helminths) can apparently cause sexually transmitted viral in-fections to be much more severe elsewhere in the body.

16 Apr 2021

A new approach to estimate the risks of exposure to COVID-19 under different indoor settings

Two MIT professors have proposed a new approach to estimating the risks of exposure to Covid-19 under different indoor settings.

16 Apr 2021

Modeling study suggests how different SARS-CoV-2 mutations prevent antibody binding

This suggests a cocktail of antibodies will work better at neutralizing the virus than a single antibody alone. In a study published in the bioRxiv* preprint server, researchers report the structure of binding complexes of the different classes of antibodies to the spike RBD using computational modeling, which may also help explain how the virus generates escape mutations.

16 Apr 2021

Study: Norovirus clusters are resistant to detergent and ultraviolet disinfection

Clusters of a virus known to cause stomach flu are resistant to detergent and ultraviolet disinfection, according to new research co-led by Danmeng Shuai, Ph.D., an associate professor of civil and environmental engineering at the George Washington University and Nihal Altan-Bonnet, Ph.D., a senior investigator and the head of the Laboratory of Host-Pathogen Dynamics at the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

16 Apr 2021

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

A number of SARS-CoV-2 variants have emerged from immunocompromised hosts, research has identified. It is thought that variants of concern - including B.1.1.7, a variant first identified in Kent - were a result of long-term infection in people with a weakened immune system.

16 Apr 2021

New model for making accurate short-term projections of COVID-19 cases

A new study by Texas A&M University researchers published in PLOS ONE details a new model for making short-term projections of daily COVID-19 cases that is accurate, reliable and easily used by public health officials and other organizations.

16 Apr 2021

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

By investigating antibody and T cell responses to a single dose of the Oxford–AstraZeneca COVID-19 vaccine, researchers from Sri Lanka and the United Kingdom have found that more than 90% of vaccinated individuals produced an adequate amount of antibodies after receiving only one dose of the vaccine – irrespective of their age and gender.

16 Apr 2021

Scientists illuminate how some antibodies can effectively disable ebolaviruses

Some survivors of ebolavirus outbreaks make antibodies that can broadly neutralize these viruses--and now, scientists at Scripps Research have illuminated how these antibodies can disable the viruses so effectively.

16 Apr 2021

Study: Previous COVID-19 infection does not completely protect against reinfection in young people

A past COVID-19 infection does not completely protect against reinfection in young people, according to an observational study of more than 3,000 healthy members of the US Marines Corps most of whom were aged 18-20 years, published in The Lancet Respiratory Medicine journal.

16 Apr 2021

Trial results show leishmaniasis vaccine is safe and induces immune responses in patients

The results of the first clinical trial of a new vaccine for a neglected tropical disease have demonstrated that it is safe and induces immune responses in patients with the infection.

15 Apr 2021

Epigenetic endowment of every person has an impact on COVID-19 severity

COVID-19, caused by the infection of the SARS-CoV-2 virus, has changed people's behavioral patterns since the moment it became a global pandemic.

15 Apr 2021

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

Researchers in the United States have demonstrated the efficacy of the vaccine INO-4800 against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

15 Apr 2021

Chile and Uruguay are experiencing their worst moment of COVID-19 pandemic

Chile and Uruguay emerged as model cases last year for their handling of the COVID-19 crisis and are among the top five countriesin the world with the most vaccine doses administered per 100 people daily.

15 Apr 2021

COVID-19 pandemic has worsened global maternal and perinatal outcomes

Immediate action is required to preserve safe maternity care worldwide, as the COVID-19 pandemic worsens global maternal and perinatal outcomes, especially in low- and middle- income countries (LMICs), a study warns.

15 Apr 2021

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research.

15 Apr 2021

CUNY SPH announces the New York State Vaccine Education and Adoption Project

In a race to transform the vaccine-hesitant into adopters in New York City and surrounding counties as Covid-19 variants rise, the CUNY Graduate School of Public Health and Health Policy has announced the New York State Vaccine Education and Adoption Project.

15 Apr 2021

Researchers develop “Nano-Glue” with therapeutic potential against SARS-CoV-2

In a recent study, researchers target the electropositive receptor-binding domain (RBD) on the SARS-CoV-2 spike protein with the abundant β-sheet structure as a novel COVID-19 therapeutic drug design.

15 Apr 2021

Virus News and Research

Latest Virus News and Research

Bristol-based new biotech company is developing ground-breaking treatments for Covid-19

Recovered COVID-19 patients may need only a single vaccine dose, suggests study

Researchers probe intriguing interaction between sugars and the SARS-CoV-2 spike protein

Intestinal worm infection can cause severe sexually transmitted viral diseases

A new approach to estimate the risks of exposure to COVID-19 under different indoor settings

Modeling study suggests how different SARS-CoV-2 mutations prevent antibody binding

Study: Norovirus clusters are resistant to detergent and ultraviolet disinfection

More SARS-CoV-2 variants have emerged from immunocompromised hosts, shows research

New model for making accurate short-term projections of COVID-19 cases

Single dose of Oxford–AstraZeneca COVID vaccine shown to be more immunogenic than natural infection

Scientists illuminate how some antibodies can effectively disable ebolaviruses

Study: Previous COVID-19 infection does not completely protect against reinfection in young people

Trial results show leishmaniasis vaccine is safe and induces immune responses in patients

Epigenetic endowment of every person has an impact on COVID-19 severity

COVID-19 vaccine INO-4800 shows efficacy against SARS-CoV-2 variants

Chile and Uruguay are experiencing their worst moment of COVID-19 pandemic

COVID-19 pandemic has worsened global maternal and perinatal outcomes

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

CUNY SPH announces the New York State Vaccine Education and Adoption Project

Researchers develop “Nano-Glue” with therapeutic potential against SARS-CoV-2

A new way of characterising biomolecules eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in